Market Synopsis of the Global
Biological computers Market
Biological computers
are systems developed form basic components such as software, hardware, input
and output. DNA and RNA are the basis of biological systems used as software
for constructing the biological systems.
Prevalence of cancer
such as lung cancer, mouth cancer, and bone cancer is on the rise across the
globe, especially in the developing countries. The market is driven by the
increasing prevalence of respiratory diseases in rural areas for developing
countries. In addition, increasing research and development activities in the
field of oncology, and technological advancements made to identify the causes
and risk factors for chronic diseases have added fuel to the global biological
computers market growth. Rising awareness about gene chip and other biological
systems that can be used for cell transformation with the help of information
technology also drives the market growth.
The global biological computers market is expected to grow at a CAGR of
7.1% during the forecast period 2017-2023.
Biological computers, also known
as DNA computers, are microcomputers designed for their use in the field of
medicine. This implantable device can be used for various functions such as
monitoring the activities of the body or inducing therapeutic effects.
Hardware, software, input, and output are the four major components of a
biological computer. These components are made of DNA, RNA and proteins.
Biological computers are able to perform mathematical calculations that enable
the researcher to construct a system of biosensors. This system of biosensors
can detect or target specific types of cells such as cancer cells in the
patient’s body.
Browse Sample of the
Report @ https://www.marketresearchfuture.com/sample_request/5067
As per the report of the Centers
for Disease Control and Prevention (CDC), in 2014, over 14.1 million of new
cancer cases were registered worldwide.
Key Players
·
Microsoft (U.S.)
·
IBM (U.S.)
·
Thermofisher Scientific (U.S.)
·
Illumina, Inc. (U.S.)
·
IndieBio (U.S.)
·
Emulate Inc. (U.S.)
Key Players manufactruing DNA or gene chips
·
Sequenom Inc.
·
Merck KGaA (U.S.)
·
Macrogen Corp (Republic of Korea)
·
Bioneer Corporation (Republic of Korea)
·
Biometrix Technology Inc (U.S.)
·
Wafergen Biosystems Inc. (U.S.)
·
Eurofins Genomics India Pvt Ltd. (India)
Segmentation
The global biological computers
market is segmented on the basis of component, application, and end user.
On the basis of the component,
market is segmented into hardware, software, input, and output.
On the basis of the application,
the market is segmented into oncology, molecular genetics, nanobiotechnology,
and others.
On the basis of the end user, the
market is segmented into pharmaceutical & biotechnology companies, research
centers, healthcare it companies, hospital & clinics, and others.
Regional Analysis
The Americas hold the first
position in the biological computers market owing to the rising prevalence of
cancer in the U.S., and increasing demand for new cancer diagnostic and
treatment services. In the Americas, North America is the largest market owing
to the presence of key players in the healthcare IT industry.
Europe is the second largest
market for biological computers. In Europe, there is an increasing demand for
healthcare IT solutions and extensive research and development activities is
taking place by clinical research and academic institutes for cancer treatment.
According to Cancer Research UK, in 2014, 356,860 new cases of cancer were
reported, including 579 cases of bone cancer.
The market in Asia Pacific is
expected to grow at the fastest pace and is driven by the high prevalence of
chronic disease such as cancer, obesity, diabetes and other. India, China, and
Japan are major contributors to the growth of the market. This growth is
attributed to an increasing demand for technologically advanced medical devices
and accessories such as gene chips for research activities. Availability of
highly qualified medical professionals dedicated to research in biological
systems is also a contributing factor. The various other factors affecting the
growth of the market in Asia Pacific are rising geriatric population, demand
for advanced therapies, government initiatives, and increasing public awareness
about various diseases and the available treatments.
Additionally, healthcare spending
in Asia Pacific expanded in 2016 due to an extension of state healthcare
programs, and the increasing affluence of the population. Organization for
Economic Co-operation and Development (ECOD) stated that growth in India will
remain high at 7.3% in 2017.
The Middle East & Africa also
show a steady rise in the market owing to low technological penetration and
increasing awareness about cancer treatment. In the Middle East & Africa,
Middle East captures the largest market share for biological medicines owing to
the availability of better healthcare infrastructure and wide scope for
research.
Browse More Details of the Report
@ https://www.marketresearchfuture.com/reports/biological-computers-market-5067
No comments:
Post a Comment